Stryker (SYK) Stock: Q1 Revenue Falls Short Amid Cyberattack Disruption

TLDR

• Stryker’s first-quarter profit was $745 million, rising from $654 million the prior year
• Revenue totaled $6.02 billion, below the $6.35 billion analysts had projected
• Adjusted earnings per share of $2.60 did not meet the $2.98 consensus estimate
• Operations and results were affected by a March cyberattack linked to Iran
• SYK shares declined approximately 2% after hours to $308.75; annual outlook was unchanged

---

(SeaPRwire) –   Stryker delivered mixed first-quarter results, with profit improving year-over-year but missing Wall Street’s revenue and earnings forecasts. The figures were affected by a cyberattack the company experienced in March.

$SYK | Stryker Corp., Q1-2026 Earning Report pic.twitter.com/yvh17fBaD9

— Hardik Shah (@AIStockSavvy) April 30, 2026

Following the earnings release, SYK stock fell around 2% in after-hours trading to $308.75.

Stryker Corporation, SYK

The company’s net income was $745 million, or $1.93 per share, compared to $654 million, or $1.69 per share, in the first quarter of 2025. Adjusted earnings were $2.60 per share, which was lower than the $2.98 analysts anticipated.

Total revenue for the quarter ending March 31 was $6.02 billion. This represented a 2.6% increase from the year-ago period but was less than the $6.35 billion consensus estimate.

Cyberattack Clouded the Quarter

During March, a hacking group with ties to Iran, named Handala, took credit for a damaging cyberattack against Stryker. The incident led to significant disruption of the company’s Microsoft systems and was said to have postponed certain surgical operations.

Employees and contractors shared on social media that the hacker group’s logo was displayed on login screens, although Reuters could not confirm these reports independently.

Stryker had previously indicated in April that the event would negatively impact first-quarter performance, which the company confirmed on Thursday.

At the time, a Wall Street Journal report stated the hackers claimed their actions were in response to rising tensions between the United States and Iran.

Segment Results Mixed

Sales in Stryker’s largest division, MedSurg and Neurotechnology, grew 5% to $3.21 billion. This result fell short of the $3.83 billion analysts had estimated.

The Orthopaedics segment performed relatively well. Its sales increased 6.3% to $2.81 billion, exceeding the $2.51 billion analysts had forecast.

Weaker demand for implants and devices utilized in complex surgeries, such as spinal and orthopedic procedures, negatively influenced the overall performance.

Stryker is a direct competitor of Zimmer Biomet (ZBH) and Johnson & Johnson (JNJ) in the orthopaedics sector, which includes areas like hip and knee replacements, trauma, and sports medicine.

In spite of the quarterly misses, Stryker reaffirmed its full-year forecast. The company repeated its expectation for adjusted annual profit between $14.90 and $15.10 per share.

This sustained guidance suggests management believes the cyberattack’s financial consequences are limited to the first quarter and will not impact the full year.

When measured against the full-year guidance of $14.90–$15.10 per share, Stryker’s Q1 adjusted EPS of $2.60 indicates the company anticipates earnings will accelerate over the next three quarters.

Stryker reiterated its full-year adjusted EPS guidance range of $14.90 to $15.10 per share.